Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 38 studies | 39% ± 18% | |
non-classical monocyte | 17 studies | 25% ± 11% | |
classical monocyte | 12 studies | 26% ± 12% | |
microglial cell | 12 studies | 40% ± 14% | |
myeloid cell | 12 studies | 40% ± 7% | |
monocyte | 7 studies | 30% ± 11% | |
conventional dendritic cell | 7 studies | 26% ± 8% | |
dendritic cell | 7 studies | 25% ± 9% | |
leukocyte | 4 studies | 31% ± 12% | |
mononuclear phagocyte | 4 studies | 36% ± 16% | |
smooth muscle cell | 3 studies | 17% ± 1% | |
tissue-resident macrophage | 3 studies | 46% ± 7% | |
intermediate monocyte | 3 studies | 35% ± 8% | |
pericyte | 3 studies | 17% ± 1% | |
alveolar macrophage | 3 studies | 24% ± 7% | |
astrocyte | 3 studies | 18% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 25% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 625.98 | 458 / 459 | 99% | 12.98 | 1104 / 1118 |
lung | 100% | 1012.77 | 578 / 578 | 95% | 11.66 | 1103 / 1155 |
thymus | 100% | 427.51 | 650 / 653 | 95% | 7.45 | 572 / 605 |
kidney | 100% | 528.62 | 89 / 89 | 94% | 16.35 | 844 / 901 |
esophagus | 94% | 316.68 | 1355 / 1445 | 91% | 8.64 | 166 / 183 |
brain | 83% | 263.16 | 2198 / 2642 | 98% | 15.51 | 694 / 705 |
pancreas | 88% | 220.11 | 289 / 328 | 91% | 7.95 | 162 / 178 |
stomach | 95% | 272.09 | 340 / 359 | 84% | 7.90 | 241 / 286 |
bladder | 100% | 500.71 | 21 / 21 | 76% | 7.54 | 385 / 504 |
intestine | 99% | 445.68 | 954 / 966 | 76% | 5.55 | 399 / 527 |
uterus | 92% | 268.51 | 157 / 170 | 81% | 6.44 | 373 / 459 |
prostate | 96% | 348.12 | 235 / 245 | 67% | 3.43 | 334 / 502 |
skin | 72% | 560.38 | 1306 / 1809 | 87% | 11.10 | 411 / 472 |
adrenal gland | 98% | 710.33 | 253 / 258 | 60% | 4.40 | 138 / 230 |
ovary | 69% | 176.12 | 124 / 180 | 86% | 8.82 | 370 / 430 |
liver | 75% | 235.04 | 169 / 226 | 65% | 4.69 | 264 / 406 |
adipose | 100% | 1079.28 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.99 | 29 / 29 |
spleen | 100% | 1923.59 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 751.19 | 849 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 8.44 | 41 / 45 |
heart | 90% | 273.53 | 771 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 86% | 405.49 | 1152 / 1335 | 0% | 0 | 0 / 0 |
muscle | 40% | 71.56 | 325 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 33% | 2.16 | 26 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043087 | Biological process | regulation of GTPase activity |
GO_0007507 | Biological process | heart development |
GO_0005740 | Cellular component | mitochondrial envelope |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0043533 | Molecular function | inositol 1,3,4,5 tetrakisphosphate binding |
GO_0005547 | Molecular function | phosphatidylinositol-3,4,5-trisphosphate binding |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0043325 | Molecular function | phosphatidylinositol-3,4-bisphosphate binding |
Gene name | ADAP2 |
Protein name | ArfGAP with dual PH domains 2 Arf-GAP with dual PH domain-containing protein 2 (Centaurin-alpha-2) (Cnt-a2) ArfGAP with dual PH domains 2 (Centaurin alpha 2) |
Synonyms | CENTA2 |
Description | FUNCTION: GTPase-activating protein for the ADP ribosylation factor family (Potential). Binds phosphatidylinositol 3,4,5-trisphosphate (PtdInsP3) and inositol 1,3,4,5-tetrakisphosphate (InsP4). Possesses a stoichiometry of two binding sites for InsP4 with identical affinity. . |
Accessions | J3QLP8 Q9NPF8 ENST00000580526.1 ENST00000581548.5 ENST00000584989.1 Q2V6Q1 ENST00000580525.5 J3QRA6 ENST00000585130.5 J3QRD3 J3KT70 J3KST1 K7ENT1 ENST00000330889.8 [Q9NPF8-1] ENST00000584828.5 ENST00000581285.5 |